Dietary phosphorus in bone health and quality of life

Nutrition Reviews

Volumn 70, Issue 6, 2012, Pages 311-321

  Takeda, Eiji ^a   Yamamoto, Hironori ^a   Yamanaka Okumura, Hisami ^a   Taketani, Yutaka ^a  

^a UNIVERSITY OF TOKUSHIMA   (Japan)

Author keywords

Bone disease; Cardiovascular disease; Phosphorus; Processed food

Indexed keywords

CALCIUM; FIBROBLAST GROWTH FACTOR 23; MAGNESIUM; NITRIC OXIDE; PARATHYROID HORMONE; PHOSPHORUS; PROTEIN; REACTIVE OXYGEN METABOLITE; RETINOL; VITAMIN D;

ARTICLE; ATHEROSCLEROSIS; BONE DENSITY; BONE MINERALIZATION; CALCIFICATION; CALCIUM METABOLISM; CARDIOVASCULAR RISK; CEREAL; CHRONIC KIDNEY DISEASE; DAIRY PRODUCT; DIET SUPPLEMENTATION; DIETARY INTAKE; DISEASE ASSOCIATION; ENDOTHELIUM CELL; FISH; FRACTURE; HEALTH STATUS; HUMAN; HYPERCALCIURIA; HYPERPHOSPHATEMIA; HYPERTENSION; ISCHEMIC HEART DISEASE; MEAT; MILK; NUTRITIONAL ASSESSMENT; NUTRITIONAL HEALTH; NUTRITIONAL REQUIREMENT; NUTRITIONAL VALUE; OSTEOLYSIS; PHOSPHATE INTAKE; PHOSPHATE METABOLISM; POSTPRANDIAL HYPERPHOSPHATEMIA; QUALITY OF LIFE; RISK ASSESSMENT; RISK BENEFIT ANALYSIS; SMOOTH MUSCLE FIBER; VASODILATATION; VEGETABLE; VITAMIN D METABOLISM;

BLOOD PRESSURE; BONE AND BONES; CARDIOVASCULAR DISEASES; DIETARY PROTEINS; HUMANS; HYPERPHOSPHATEMIA; HYPOPHOSPHATEMIA; PHOSPHORUS, DIETARY; QUALITY OF LIFE; RISK FACTORS;

EID: 84861658884     PISSN: 00296643     EISSN: 17534887     Source Type: Journal    
DOI: 10.1111/j.1753-4887.2012.00473.x     Document Type: Article

References (131)

1. Takeda E, Taketani Y, Morita K, etal. Molecular mechanisms of mammalian inorganic phosphate homeostasis. Adv Enzyme Regul. 2000;40:285-302.
2. Bringhurst FR, Demay BM, Krane SM, etal. Bone and mineral metabolism in health and disease. In: Kasper DL, Braunwald E, Fauci AS, etal., eds. Harrison's Principles of Internal Medicine. New York, NY: McGraw-Hill; 2004:2238-2249.
3. Fukagawa M, Kurokawa K, Papadakis MA. Fluid and electrolyte disorders. In: Tierney LM, McPhee SJ, Papadakis MA, eds. Current Medical Diagnosis and Treatment 2005. New York, NY: McGraw-Hill/Appleton & Lange; 2004:837-867.
4. Blumsohn A. What have we learnt about the regulation of phosphate metabolism? Curr Opin Nephrol Hypertens. 2004;13:397-401.
5. Ravid M, Robson M. Proximal myopathy caused by latrogenic phosphate depletion. JAMA. 1976;236:1380-1381.
6. Knochel JP, Barcenas C, Cotton JR, etal. Hypophosphatemia and rhabdomyolysis. J Clin Invest. 1978;62:1240-1246.
7. Knochel JP, Bilbrey GL, Fuller TJ, etal. The muscle cell in chronic alcoholism: the possible role of phosphate depletion in alcoholic myopathy. Ann N Y Acad Sci. 1975;252:274-286.
8. Lotz M, Zisman E, Bartter FC. Evidence for a phosphorus-depletion syndrome in man. N Engl J Med. 1968;278:409-415.
9. Boukhris R, Becker KL. Calcification of the aorta and osteoporosis. A roentgenographic study. JAMA. 1972;219:1307-1311.
10. Adeney K, Siscovick D, Ix J, etal. Association of serum phosphate with vascular and valvular calcification in moderate CKD. J Am Soc Nephrol. 2009;20:381-387.
11. Kestenbaum B, Sampson JN, Rudser KD, etal. Serum phosphate levels and mortality risk among people with chronic kidney disease. J Am Soc Nephrol. 2005;16:520-528.
12. Dhingra R, Sullivan LM, Fox CS, etal. Relations of serum phosphorus and calcium levels to the incidence of cardiovascular disease in the community. Arch Intern Med. 2007;167:879-885.
13. Tonelli M, Sacks F, Pfeffer M, etal. Relation between serum phosphate level and cardiovascular event rate in people with coronary disease. Circulation. 2005;112:2627-2633.
14. Narang R, Ridout D, Nonis C, etal. Serum calcium, phosphorus and albumin levels in relation to the angiographic severity of coronary artery disease. Int J Cardiol. 1997;60:73-79.
15. Takeda E, Sakamoto K, Yokota K, etal. Phosphorus supply per capita from food in Japan between 1960 and 1995. J Nutr Sci Vitaminol (Tokyo). 2002;48:102-108.
16. Calvo MS, Park YK. Changing phosphorus content of the U.S. diet: potential for adverse effects on bone. J Nutr. 1996;126(Suppl):S1168-S11180.
17. Willett WC, Buzzard M. Nature of variation in diet. In: Willett WC, ed. Nutritional Epidemiology, 2nd ed. New York: Oxford University Press; 1998:33-49.
18. Murphy-Gutekunst L. Hidden phosphorus: where do we go from here? J Ren Nutr. 2007;4:e31-e36.
19. Sherman RA, Mehta O. Phosphorus and potassium content of enhanced meat and poultry products: implications for patients who receive dialysis. Clin J Am Soc Nephrol. 2009;4:1370-1373.
20. Sherman RA, Mehta O. Dietary phosphorus restriction in dialysis patients: potential impact of processed meat, poultry, and fish products as protein sources. Am J Kidney Dis. 2009;54:18-23.
21. Sullivan CM, Leon JB, Sehgal AR. Phosphorus-containing food additives and the accuracy of nutrient databases: implications for renal patients. J Ren Nutr. 2007;17:350-354.
22. Uribarri J, Calvo MS. Hidden sources of phosphorus in the typical American diet: does it matter in nephrology? Semin Dial. 2003;16:186-188.
23. Karalis M. Food and Drug Administration petition on food labeling: an update from the American Dietetic Association and National Kidney Foundation. J Ren Nutr. 2007;17:423-424.
24. Sehgal AR, Sullivan C, Leon JB, etal. Public health approach to addressing hyperphosphatemia among dialysis patients. J Ren Nutr. 2008;18:256-261.
25. Oenning LL, Vogel J, Calvo MS. Accuracy of methods estimating calcium and phosphorus intake in daily diets. J Am Diet Assoc. 1988;88:1076-1080.
26. Baker EA, Schootman M, Barnidge E, etal. The role of race and poverty in access to foods that enable individuals to adhere to dietary guidelines. Prev Chronic Dis. 2006;3:A76.
27. Block JP, Scribner RA, DeSalvo KB. Fast food, race/ethnicity, and income: a geographic analysis. Am J Prev Med. 2004;27:211-217.
28. Powell LM, Chaloupka FJ, Bao Y. The availability of fastfood and full-service restaurants in the United States: associations with neighborhood characteristics. Am J Prev Med. 2007;33 (Suppl):S240-S245.
29. Butt S, Leon JB, David CL, etal. The prevalence and nutritional implications of fast food consumption among patients receiving hemodialysis. J Ren Nutr. 2007;17:264-268.
30. Gutiérrez OM, Isakova T, Enfield G, etal. Impact of poverty on serum phosphate concentrations in the Third National Health and Nutrition Examination Survey. J Ren Nutr. 2011;21:140-148.
31. Gutiérrez OM, Anderson C, Isakova T, etal. Low socioeconomic status associates with higher serum phosphate irrespective of race. J Am Soc Nephrol. 2010;21:1953-1960.
32. Welch AA, Fransen H, Jenab M, etal. Variation in intakes of calcium, phosphorus, magnesium, iron and potassium in 10 countries in the European Prospective Investigation into Cancer and Nutrition study. Eur J Clin Nutr. 2009;63(Suppl 4):S101-S121.
33. Moe SM, Zidehsarai MP, Chambers MA, etal. Vegetarian compared with meat dietary protein source and phosphorus homeostasis in chronic kidney disease. Clin J Am Soc Nephrol. 2010;6:257-264.
34. Murer H, Hernando N, Forster I, etal. Proximal tubular phosphate reabsorption: molecular mechanisms. Physiol Rev. 2000;80:1373-1409.
35. Miyamoto K, Ito M, Tatsumi S. New aspect of renal phosphate reabsorption: the type IIc sodium-dependent phosphate transporter. Am J Nephrol. 2007;27:503-515.
36. Tenenhouse HS. Regulation of phosphorus homeostasis by the type IIa Na/phosphate cotransporter. Annu Rev Nutr. 2006;25:197-214.
37. Biber J, Hernando N, Forster I, etal. Regulation of phosphate transport in proximal tubules. Pflugers Arch. 2009;458:39-52.
38. Xu H, Bai L, Collins JF, etal. Age-dependent regulation of rat intestinal type IIb sodium-phosphate cotransporter by 1, 25-(OH2) vitamin D3. Am J Physiol Cell Physiol. 2002;282:C487-C493.
39. Segawa H, Kaneko I, Setsuko Y, etal. Intestinal Na-Pi cotransporter adaptation to dietary Pi content in vitamin D receptor null mice. Am J Physiol Renal Physiol. 2004;287:F39-F47.
40. Yu X, White KE. Fibroblast growth factor 23 and its receptors. Ther Apher Dial. 2005;9:308-312.
41. Yu X, White KE. FGF23 and disorders of phosphate homeostasis. Cytokine Growth Factor Rev. 2005;16:221-232.
42. Prié D, Ureña Torres P, Friedlander G. Latest findings in phosphate homeostasis. Kidney Int. 2009;75:882-889.
43. Komaba H, Fukagawa M. FGF23-parathyroid interaction: implications in chronic kidney disease. Kidney Int. 2010;77:292-298.
44. Urakawa I, Yamazaki Y, Shimada T, etal. Klotho converts canonical FGF receptor into a specific receptor for FGF23. Nature. 2006;444:770-774.
45. Antoniucci DM, Yamashita T, Portale AA. Dietary phosphorus regulates serum fibroblast growth factor-23 concentrations in healthy men. J Clin Endocrinol Metab. 2006;91:3144-3149.
46. Burnett SM, Gunawardene SC, Bringhurst FR, etal. Regulation of C-terminal and intact FGF-23 by dietary phosphate in men and women. J Bone Miner Res. 2006;21:1187-1196.
47. Ferrari SL, Bonjour JP, Rizzoli R. FGF-23 relationship to dietary phosphate and renal phosphate handling in healthy young men. J Clin Endocrinol Metab. 2005;90:1519-1524.
48. Saito H, Maeda A, Ohtomo S, etal. Circulating FGF-23 is regulated by 1alpha, 25-dihydroxyvitamin D3 and phosphorus in vivo. J Biol Chem. 2005;280:2543-2549.
49. Nishida Y, Taketani Y, Yamanaka-Okumura H, etal. Acute effect of oral phosphate loading on serum fibroblast growth factor 23 levels in healthy men. Kidney Int. 2006;70:2141-2147.
50. Larsson T, Nisbeth U, Ljunggren O, etal. Circulating concentration of FGF-23 increases as renal function declines in patients with chronic kidney disease, but does not change in response to variation in phosphate intake in healthy volunteers. Kidney Int. 2003;64:2272-2279.
51. Gutierrez O, Isakova T, Rhee E, etal. Fibroblast growth factor-23 mitigates hyperphosphatemia but accentuates calcitriol deficiency in chronic kidney disease. J Am Soc Nephrol. 2005;16:2205-2215.
52. Wolf M. Fibroblast growth factor 23 and the future of phosphorus management. Curr Opin Nephrol Hypertens. 2009;18:463-468.
53. Kuro-o M, Matsumura Y, Aizawa H, etal. Mutation of the mouse klotho gene leads to a syndrome resembling aging. Nature. 1997;390:45-51.
54. Shimada T, Kakitani M, Yamazaki Y, etal. Targeted ablation of FGF23 demonstrates an essential physiological role of FGF23 in phosphate and vitamin D metabolism. J Clin Invest. 2004;113:561-568.
55. Arking DE, Atzmon G, Arking A, etal. Association between a functional variant of the KLOTHO gene and high-density lipoprotein cholesterol, blood pressure, stroke, and longevity. Circ Res. 2005;96:412-418.
56. Morishita K, Shirai A, Kubota M, etal. The progression of aging in klotho mutant mice can be modified by dietary phosphorus and zinc. J Nutr. 2001;131:3182-3188.
57. Stubbs JR, Liu S, Tang W, etal. Role of hyperphosphatemia and 1, 25-dihydroxyvitamin D in vascular calcification and mortality in fibroblastic growth factor 23 null mice. J Am Soc Nephrol. 2007;18:2116-2124.
58. Calvo MS. Dietary phosphorus, calcium metabolism and bone. J Nutr. 1993;123:1627-1633.
59. Heaney RP. Protein and calcium: antagonists or synergist? Am J Clin Nutr. 2002;75:609-610.
60. Schurch MA, Rizzoli R, Slosman D, etal. Protein supplements increase serum insulin-like growth factor-I level and attenuate proximal femur bone loss in patients with recent hip fracture. A randomized, doublebind, placebo-controlled trial. Ann Intern Med. 1998;128:801-809.
61. Amato D, Maravilla A, Montoya C, etal. Acute effects of soft drink intake on calcium and phosphate metabolism in immature and adult rats. Rev Invest Clin. 1998;50:185-189.
62. Tucker KL, Morita K, Qiao N, etal. Colas, but not other carbonated beverages, are associated with low bone mineral density in older women: the Framingham Osteoporosis Study. Am J Clin Nutr. 2006;84:936-942.
63. Fernando GR, Martha RM, Evangelina R. Consumption of soft drinks with phosphoric acid as a risk factor for the development of hypocalcemia in postmenopausal women. J Clin Epidemiol. 1999;52:1007-1010.
64. Remer T, Manz F. Estimation of the renal net acid excretion by adults consuming diets containing variable amounts of protein. Am J Clin Nutr. 1994;59:1356-1361.
65. Sebastian A, Frassetto LA, Sellmeyer DE, etal. Estimation of the net acid load of the diet of ancestral preagricultural Homo sapiens and their hominid ancestors. Am J Clin Nutr. 2002;76:1308-1316.
66. New SA. Nutrition Society Medal lecture. The role of the skeleton in acid-base homeostasis. Proc Nutr Soc. 2002;61:151-164.
67. Portale AA, Halloran BP, Morris C. Dietary intake of phosphorus modulates the circadian rhythm in serum concentration of phosphorus. J Clin Invest. 1987;80:1147-1154.
68. Moe SM, Chen NX. Pathophysiology of vascular calcification in chronic kidney disease. Circ Res. 2004;95:560-567.
69. Jono S, McKee MD, Murry CE, etal. Phosphate regulation of vascular smooth muscle cell calcification. Circ Res. 2000;87:e10-e17.
70. Giachelli CM. Vascular calcification: in vitro evidence for the role of inorganic phosphate. J Am Soc Nephrol. 2003;14(Suppl):S300-S304.
71. Onufrak SJ, Bellasi A, Shaw LJ, etal. Phosphorus levels are associated with subclinical atherosclerosis in the general population. Atherosclerosis. 2008;199:424-431.
72. Shuto E, Taketani Y, Tanaka R, etal. Dietary phosphorus acutely impairs endothelial function. J Am Soc Nephrol. 2009;20:1504-1512.
73. de Boer IH, Rue TC, Kestenbaum B. Serum phosphorus concentrations in the third National Health and Nutrition Examination Survey (NHANES III). Am J Kidney Dis. 2009;53:399-407.
74. Lippi G, Montagnana M, Salvagno GL, etal. Relationship between serum phosphate and cardiovascular risk factors in a large cohort of adult outpatients. Diabetes Res Clin Pract. 2009;84:e3-e5.
75. Poduval RD, Wolgemuth C, Ferrell J, etal. Hyperphosphatemia in dialysis patients: is there a role for focused counseling? J Renal Nutr. 2003;13:219-223.
76. Block GA, Hulbert-Shearon TE, Levin NW, etal. Association of serum phosphorus and calcium x phosphorus product with mortality risk in chronic hemodialysis patients: a national study. Am J Kidney Dis. 1998;31:607-617.
77. Stevens LA, Djurdjev O, Cardew S, etal. Calcium, phosphate, and parathyroid hormone levels in combination and as a function of dialysis duration predict mortality: evidence for the complexity of the association between mineral metabolism and outcomes. J Am Soc Nephrol. 2004;15:770-779.
78. Young EW, Albert JM, Satayathum S, etal. Predictors and consequences of altered mineral metabolism: the Dialysis Outcomes and Practice Patterns Study. Kidney Int. 2005;67:1179-1187.
79. Mathew S, Tustison KS, Sugatani T, etal. The mechanism of phosphorus as a cardiovascular risk factor in CKD. J Am Soc Nephrol. 2008;19:1092-1105.
80. Amann K, Tornig J, Kugel B, etal. Hyperphosphatemia aggravates cardiac fibrosis and microvascular disease in experimental uremia. Kidney Int. 2003;63:1296-1301.
81. Ibels LS, Alfrey AC, Haut L, etal. Preservation of function in experimental renal disease by dietary restriction of phosphate. N Engl J Med. 1978;298:122-126.
82. Elliott P, Kesteloot H, Appel LJ, etal. Dietary phosphorus and blood pressure. International Study of Macro- and Micro-nutrients and Blood Pressure. Hypertension. 2008;51:669-675.
83. Joffres MR, Reed DM, Yano K. Relationship of magnesium intake and other dietary factors to blood pressure: the Honolulu Heart Study. Am J Clin Nutr. 1987;45:469-475.
84. Beydoun MA, Gary TL, Caballero BH, etal. Ethnic differences in dairy and related nutrient consumption among US adults and their association with obesity, central obesity, and the metabolic syndrome. Am J Clin Nutr. 2008;87:1914-1925.
85. Harlan WR, Hull AL, Schmouder RL, etal. Blood pressure and nutrition in adults: the National Health and Nutrition Examination Survey. Am J Epidemiol. 1984;120:17-28.
86. Alonso A, Nettleton JA, Ix JH, etal. Dietary phosphorus, blood pressure and incidence of hypertension in the Atherosclerosis Risk in Communities (ARIC) Study and the Multi-Ethnic Study of Atherosclerosis (MESA). Hypertension. 2010;55:776-784.
87. Scragg R, Sowers M, Bell C. Serum 25-hydroxyvitamin D, ethnicity, and blood pressure in the Third National Health and Nutrition Examination Survey. Am J Hypertens. 2007;20:713-719.
88. Foley RN, Collins AJ, Ishani A, Kalra PA. Calcium-phosphate levels and cardiovascular disease in community-dwelling adults: the Atherosclerosis Risk in Communities (ARIC) Study. Am Heart J. 2008;156:556-563.
89. Pfeuffer M, Schrezenmeir J. Milk and the metabolic syndrome. Obesity Reviews. 2006;8:109-118.
90. Allender PS, Cutler JA, Follmann D, etal. Dietary calcium and blood pressure: a meta-analysis of randomized controlled trials. Ann Intern Med. 1996;124:825-831.
91. Griffith LE, Guyatt GH, Cook RJ, etal. The influence of dietary and nondietary calcium supplementation on blood pressure: an updated metaanalysis of randomized controlled trials. Am J Hypertens. 1999;12:84-92.
92. van Mierlo LAJ, Arends LR, Streppel MT, etal. Blood pressure response to calcium supplementation: a meta-analysis of randomised controlled trials. J Hum Hypertens. 2006;20:571-580.
93. Jee SH, Miller ER III, Guallar E, etal. The effect of magnesium supplementation on blood pressure: a meta-analysis of randomized clinical trials. Am J Hypertens. 2002;15:691-696.
94. Hruska K, Slatopolsky E. Disorders of phosphorus, calcium, and magnesium metabolism. In: Schrier R, Gottschalk C, eds. Diseases of the Kidney, Vol. 3. London, UK: Little, Brown; 1996:2477-2526.
95. Portale AA, Halloran BP, Morris C. Physiologic regulation of the serum concentration of 1, 25-dihydroxyvitamin D by phosphorus in normal men. J Clin Invest. 1989;83:1494-1499.
96. Institute of Medicine. Dietary Reference Intakes. Calcium, Phosphorus, Magnesium, Vitamin D, and Fluoride. Washington, DC: National Academy Press; 1997.
97. Dawson-Hughes B. Calcium supplementation and bone mass: a review of controlled clinical trials. Am J Clin Nutr. 1991;54(Suppl 1):S274-S280.
98. Key TJ, Appleby PN, Spencer EA, etal. Calcium, diet and fracture risk: a prospective study of 1898 incident fractures among 34, 696 British women and men. Public Health Nutrition. 2007;10:1314-1320.
99. Wyshak G, Frisch RE, Albright TE, etal. Nonalcoholic carbonated beverage consumption and bone fractures among women former college athletes. J Orthop Res. 1989;7:91-99.
100. Wyshak G, Frisch RE. Carbonated beverages, dietary calcium, the dietary calcium/phosphorus ratio, and bone fractures in girls and boys. J Adolesc Health. 1994;15:210-215.
101. Harnack L, Stang J, Story M. Soft drink consumption among US children and adolescents: nutritional consequences. J Am Diet Assoc. 1999;99:436-441.
102. Elwood PC, Pickering JE, Hughes J, etal. Milk drinking, ischaemic heart disease and ischaemic study II. Evidence from cohort studies. Eur J Clin Nutr. 2004;58:718-724.
103. Elwood PC, Pickering JE, Fehily AM, etal. Milk drinking ischaemic heart disease and ischemic stroke I. Evidence from the Caerphilly cohort. Eur J Clin Nutr. 2004;58:711-717.
104. Hu FB, Stampfer MJ, Manson JE, etal. Dietary saturated fats and their food sources in relation to the risk of coronary heart disease in women. Am J Clin Nutr. 1999;70:1001-1008.
105. Wang L, Manson JE, Buring JE, etal. Dietary intake of dairy products, calcium, and vitamin D and the risk of hypertension in middle-aged and older women. Hypertension. 2008;51:1073-1079.
106. Dietary Guidelines Advisory Committee Report, U.S. Department of Health and Human Services and U.S. Department of Agriculture. Dietary Guidelines for Americans. 6th ed. Washington, DC: U.S. Government; 2005. Available at:, 1012.
107. Heaney RP. Dairy and bone health. J Am Coll Nutr. 2009;28(Suppl):S82-S90.
108. Heaney RP, Weaver CM. Newer perspectives on calcium and bone quality. J Am Coll Nutr. 2005;24(Suppl):S574-S581.
109. Calvo MS, Kumar R, Heath H 3rd. Elevated secretion and action of serum parathyroid hormone in young adults consuming high phosphorus, low calcium diets assembled from common foods. J Clin Endocrinol Metab. 1988;66:823-829.
110. Calvo MS, Kumar R, Heath H 3rd. Persistently elevated parathyroid hormone secretion and action in young women after four weeks of ingesting high phosphorus, low calcium diets. J Clin Endocrinol Metab. 1990;70:1334-1340.
111. Silver J, Naveh-Many T. Phosphate and the parathyroid. Kidney Int. 2009;75:898-905.
112. Kristensen M, Jensen M, Kudsk J, etal. Short-term effects on bone turnover of replacing milk with cola beverages: a 10-day interventional study in young men. Osteoporos Int. 2005;16:1803-1808.
113. Koshihara M, Katsumata S, Uehara M, etal. Effects of dietary phosphorus intake on bone mineralization and calcium absorption in adult female rats. Biosci Biotechnol Biochem. 2005;69:1025-1028.
114. Huttunen MM, Pietilä PE, Viljakainen HT, etal. Prolonged increase in dietary phosphate intake alters bone mineralization in adult male rats. J Nutr Biochem. 2006;17:479-484.
115. Sax L. The Institute of Medicine's "dietary reference intake" for phosphorus: a critical perspective. J Am Coll Nutr. 2001;20:271-278.
116. Kemi VE, Kärkkäinen MU, Karp HJ, etal. Increased calcium intake does not completely counteract the effects of increased phosphorus intake on bone: an acute dose-response study in healthy females. Br J Nutr. 2008;99:832-839.
117. Nieves JW. Osteoporosis: the role of micronutrients. Am J Clin Nutr. 1991;81(Suppl):S1232-S1239.
118. Moore LL, Singer MR, Bradlee ML, etal. Intake of fruits, vegetables, and dairy products in early childhood and subsequent blood pressure change. Epidemiology. 2005;16:4-11.
119. Pereira MA, Jacobs DR Jr, Van Horn L, etal. Dairy consumption, obesity, and the insulin resistance syndrome in young adults. The CARDIA Study. JAMA. 2002;287:2081-2089.
120. Alonso A, Beunza JJ, Delgado-Rodríguez M, etal. Low-fat dairy consumption and reduced risk of hypertension: the Seguimiento Universidad de Navarra (SUN) cohort. Am J Clin Nutr. 2005;82:972-979.
121. Wang L, Manson JE, Buring JE, etal. Dietary intake of dairy products, calcium, and vitamin D and the risk of hypertension in middle-aged and older women. Hypertension. 2008;51:1-7.
122. Engberink MF, Hendriksen MAH, Schouten EG, etal. Inverse association between dairy intake and hypertension: the Rotterdam Study. Am J Clin Nutr. 2009;89:1877-1883.
123. Steffen LM, Kroenke CH, Yu X, etal. Associations of plant food, dairy product, and meat intakes with 15-year incidence of elevated blood pressure in young black and white adults: the Coronary Artery Risk Development in Young Adults (CARDIA) Study. Am J Clin Nutr. 2005;82:1169-1177.
124. Alonso A, Steffen LM, Folsom AR. Dairy intake and changes in blood pressure over 9 years: the ARIC study. Eur J Clin Nutr. 2009;63:1272-1275.
125. Jacobs DR Jr, Tapsell LC. Food, not nutrients, is the fundamental unit in nutrition. Nutr Rev. 2007;65:439-450.
126. Ranganathan R, Nicklas TA, Yang SJ, Berenson GS. The nutritional impact of dairy product consumption on dietary intakes of adults (1995-1996): the Bogalusa Heart Study. J Am Diet Assoc. 2005;105:1391-1400.
127. Fulgoni V III, Nicholls J, Reed A, etal. Dietary consumption and related nutrient intake in African-American adults and children in the United States: continuing survey of food intakes by individuals 1994-1996, 1998, and the National Health and Nutrition Examination Survey 1999-2000. J Am Diet Assoc. 2007;107:256-264.
128. Barger-Lux MJ, Heaney RP, Packard PT, etal. Nutritional correlations of low calcium intake. Clin Appl Nutr. 1992;2:39-44.
129. Gao V, Wilde PE, Lichtenstein AH, etal. Meeting adequate intake for dietary calcium without dairy foods in adolescents aged 9 to 18 years (National Health and Nutrition Examination Survey 2001-2002). J Am Diet Assoc. 2006;106:1759-1765.
130. Uribarri J. Phosphorus homeostasis in chronic kidney disease patients with special emphasis on dietary phosphorus intake. Semin Dial. 2007;20:295-301.
131. Uribarri J, Calvo MS. Hidden sources of phosphorus in the typical American diet: does it matter in nephrology? Semin Dial. 2003;16:35-41.